Ischemic stroke in a man using estrogen

Journal of Stroke and Cerebrovascular Diseases

Volumn 11, Issue 2, 2002, Pages 117-118

  Egan, Robert A ^a   Kuyl, Jennifer M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Estrogen; Progesterone; Stroke; Transsexual

Indexed keywords

ESTRADIOL; ESTROGEN; MEDROXYPROGESTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; ESTROGEN THERAPY; HEMIPARESIS; HUMAN; MALE; NEGLECT; PRIORITY JOURNAL; RIGHT HEMISPHERE; SEX TRANSFORMATION; STROKE; TRANSSEXUALISM; VISUAL FIELD DEFECT;

EID: 0036522432     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2002.126693     Document Type: Article

References (6)

1. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA 2000;284:72-78.
2. DeMarinis M, Arnett EN. Cerebrovascular occlusion in a transsexual man taking mestranol. Arch Intern Med 1978;138:1732-1733.
3. Biller J, Saver JL. Ischemic cerebrovascular disease and hormone therapy for infertility and transsexualism. Neurology 1995;45:1611-1613.
4. Petitti DB, Sidney S, Quesenberry CP, et al. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998;29:23-28.
5. Simon JA, Hsia J, Cauley JA, et al. Postmenopausal hormone therapy and risk of stroke: The heart and estrogen-progestin replacement study (HERS). Circulation 2001;103:638-642.
6. Pedersen AT, Lidegaard O, Kreiner S, et al. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997;350:1277-1283.